For: | Sterclova M, Vasakova M. Promising new treatment targets in patients with fibrosing lung disorders. World J Clin Cases 2014; 2(11): 668-675 [PMID: 25405190 DOI: 10.12998/wjcc.v2.i11.668] |
---|---|
URL: | https://www.wjgnet.com/2307-8960/full/v2/i11/668.htm |
Number | Citing Articles |
1 |
Jacopo Di Gregorio, Iole Robuffo, Sonia Spalletta, Giulia Giambuzzi, Vincenzo De Iuliis, Elena Toniato, Stefano Martinotti, Pio Conti, Vincenzo Flati. The Epithelial-to-Mesenchymal Transition as a Possible Therapeutic Target in Fibrotic Disorders. Frontiers in Cell and Developmental Biology 2020; 8 doi: 10.3389/fcell.2020.607483
|
2 |
Daniele Magnini, Giuliano Montemurro, Bruno Iovene, Linda Tagliaboschi, Rafael Emanuele Gerardi, Erminia Lo Greco, Teresa Bruni, Alessio Fabbrizzi, Francesco Lombardi, Luca Richeldi. Idiopathic Pulmonary Fibrosis: Molecular Endotypes of Fibrosis Stratifying Existing and Emerging Therapies. Respiration 2017; 93(6): 379 doi: 10.1159/000475780
|
3 |
Xinyuan Zhao, Saisai Wei, Zhijian Li, Chen Lin, Zhenfeng Zhu, Desen Sun, Rongpan Bai, Jun Qian, Xiangwei Gao, Guangdi Chen, Zhengping Xu. Autophagic flux blockage in alveolar epithelial cells is essential in silica nanoparticle-induced pulmonary fibrosis. Cell Death & Disease 2019; 10(2) doi: 10.1038/s41419-019-1340-8
|